Genome Editing Market Forecast (2024-2032)

The latest analysis offers a comprehensive overview of the market, highlighting factors that could influence future growth, potential opportunities, and current trends. It includes an analysis of market revenue size, drivers, constraints, and opportunities.

Want a Free Sample or want to Customize the Report, click here and we will get back to you shortly with the details you need.

The Genome Editing Market research is instrumental in the assessment of numerous critical criteria, such as the success of the product, the expansion of market share, and the investment in a developing market. The most recent analysis will offer a comprehensive overview of the Genome Editing Market, including variables that may impact future growth, potential prospects, and current trends. The research encompasses an examination of the revenue market size, as well as market drivers, constraints, and opportunities. The study also illustrates the competitive landscape of the industry’s major competitors and the percentage market share of the top organizations.

This investigation analyzes the market structure, market segmentation, growth rates, and revenue share comparisons. This report offers a comprehensive analysis of the market and its potential. The genome editing market is the subject of this study, which is in-depth. The market estimates and predictions in the research report are the result of extensive secondary research, primary interviews, and in-house expert opinions. These market projections and estimates take into account the influence of a diverse array of political, social, and economic factors, as well as current market conditions, on market growth.

 Market Segmentation

This investigation explores the current state of the industry in each sub-segment, as well as revenue growth at the country level. This segmentation provides a comprehensive understanding of the market and enables you to monitor its development. This section analyzes the Genome Editing Market market’s segmentation by regions and countries, as well as a breakdown of revenues, market shares, and potential growth opportunities.

Key Segments:
By Technology
Meganucleases
(CRISPR)/Cas9
TALENs/MegaTALs
ZFN
Others

By Delivery Method
Ex-vivo
In-vivo

By Mode
Contract
In-house

By Application
Genetic Engineering
Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering
Others
linical Applications
Diagnostics
Therapy Development

By End User
Biotechnology & Pharmaceutical Companies
Academic & Government Research Institutes
Contract Research Organizations

COVID-19 Impact Analysis

The impact of COVID-19 on the Genome Editing Market at the country level is the subject of this research report. Market participants will be able to implement pandemic preparedness strategies with the help of the COVID-19 impact analysis. The demand and supply side effects of the target market are the focus of this investigation. This investigation made use of private databases, a paid data source, and primary and secondary research.

Key Market Players

  • Merck KGaA
  • Cibus
  • Recombinetics Inc.
  • Sangamo
  • Precision Biosciences
  • CRISPR TherapeuticIntellia Therapeutics Inc.
  • Caribou Biosciences Inc.
  • AstraZeneca
  • Takara Bio USA
  • Horizon Discovery Group plc
  • Integrated DNA Technologies Inc.
  • Egenesis Inc.
  • GenScript
  • New England Biolabs
  • OriGene Technologies Inc.
  • Lonza
  • Thermo Fisher Scientific Inc and other.

TABLE OF CONTENTS

1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions

2. Research Methodology

3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges

4. Impact Analysis
4.1 Impact of the Russia-Ukraine War
4.2 Impact of Ongoing Recession
4.2.1 Introduction
4.2.2 Impact on major economies
4.2.2.1 US
4.2.2.2 Canada
4.2.2.3 Germany
4.2.2.4 France
4.2.2.5 United Kingdom
4.2.2.6 China
4.2.2.7 Japan
4.2.2.8 South Korea
4.2.2.9 Rest of the World

5. Value Chain Analysis

6. Porter’s 5 forces model

7. PEST Analysis

8. Genome Editing Market Segmentation, By Technology
8.1 Meganucleases
8.2 (CRISPR)/Cas9
8.3 TALENs/MegaTALs
8.4 ZFN
8.5 Others

9. Genome Editing Market Segmentation, By Delivery Method
9.1 Ex-vivo
9.2 In-vivo

10. Genome Editing Market Segmentation, By Mode
10.1 Contract
10.2 In-house

11. Genome Editing Market Segmentation, By Application
11.1 Genetic Engineering
11.1.1 Cell Line Engineering
11.1.2 Animal Genetic Engineering
11.1.3 Plant Genetic Engineering
11.2 Clinical Applications
11.2.1 Diagnostics
11.2.2 Therapy Development

12. Genome Editing Market Segmentation, By End user
12.1 Biotechnology & Pharmaceutical Companies
12.2 Academic & Government Research Institutes
12.3 Contract Research Organizations

13. Regional Analysis
13.1 Introduction
13.2 North America
13.2.1 North America Genome Editing Market by Country
13.2.2 North America Genome Editing Market by Technology
13.2.3 North America Genome Editing Market by Delivery Method
13.2.4 North America Genome Editing Market by Mode
13.2.5 North America Genome Editing Market by Application
13.2.6 North America Genome Editing Market by End user
13.2.7 USA
13.2.7.1 USA Genome Editing Market by Technology
13.2.7.2 USA Genome Editing Market by Delivery Method
13.2.7.3 USA Genome Editing Market by Mode
13.2.7.4 USA Genome Editing Market by Application
13.2.7.5 USA Genome Editing Market by End user
13.2.8 Canada
13.2.8.1 Canada Genome Editing Market by Technology
13.2.8.2 Canada Genome Editing Market by Delivery Method
13.2.8.3 Canada Genome Editing Market by Mode
13.2.8.4 Canada Genome Editing Market by Application
13.2.8.5 Canada Genome Editing Market by End user
13.2.9 Mexico
13.2.9.1 Mexico Genome Editing Market by Technology
13.2.9.2 Mexico Genome Editing Market by Delivery Method
13.2.9.3 Mexico Genome Editing Market by Mode
13.2.9.4 Mexico Genome Editing Market by Application
13.2.9.5 Mexico Genome Editing Market by End user
13.3 Europe
13.3.1 Eastern Europe
13.3.1.1 Eastern Europe Genome Editing Market by Country
13.3.1.2 Eastern Europe Genome Editing Market by Technology
13.3.1.3 Eastern Europe Genome Editing Market by Delivery Method
13.3.1.4 Eastern Europe Genome Editing Market by Mode
13.3.1.5 Eastern Europe Genome Editing Market by Application
13.3.1.6 Eastern Europe Genome Editing Market by End user
13.3.1.7 Poland
13.3.1.7.1 Poland Genome Editing Market by Technology
13.3.1.7.2 Poland Genome Editing Market by Delivery Method
13.3.1.7.3 Poland Genome Editing Market by Mode
13.3.1.7.4 Poland Genome Editing Market by Application
13.3.1.7.5 Poland Genome Editing Market by End user
13.3.1.8 Romania
13.3.1.8.1 Romania Genome Editing Market by Technology
13.3.1.8.2 Romania Genome Editing Market by Delivery Method
13.3.1.8.3 Romania Genome Editing Market by Mode
13.3.1.8.4 Romania Genome Editing Market by Application
13.3.1.8.5 Romania Genome Editing Market by End user
13.3.1.9 Hungary
13.3.1.9.1 Hungary Genome Editing Market by Technology
13.3.1.9.2 Hungary Genome Editing Market by Delivery Method
13.3.1.9.3 Hungary Genome Editing Market by Mode
13.3.1.9.4 Hungary Genome Editing Market by Application
13.3.1.9.5 Hungary Genome Editing Market by End user
13.3.1.10 Turkey
13.3.1.10.1 Turkey Genome Editing Market by Technology
13.3.1.10.2 Turkey Genome Editing Market by Delivery Method
13.3.1.10.3 Turkey Genome Editing Market by Mode
13.3.1.10.4 Turkey Genome Editing Market by Application
13.3.1.10.5 Turkey Genome Editing Market by End user
13.3.1.11 Rest of Eastern Europe
13.3.1.11.1 Rest of Eastern Europe Genome Editing Market by Technology
13.3.1.11.2 Rest of Eastern Europe Genome Editing Market by Delivery Method
13.3.1.11.3 Rest of Eastern Europe Genome Editing Market by Mode
13.3.1.11.4 Rest of Eastern Europe Genome Editing Market by Application
13.3.1.11.5 Rest of Eastern Europe Genome Editing Market by End user
13.3.2 Western Europe
13.3.2.1 Western Europe Genome Editing Market by Country
13.3.2.2 Western Europe Genome Editing Market by Technology
13.3.2.3 Western Europe Genome Editing Market by Delivery Method
13.3.2.4 Western Europe Genome Editing Market by Mode
13.3.2.5 Western Europe Genome Editing Market by Application
13.3.2.6 Western Europe Genome Editing Market by End user
13.3.2.7 Germany
13.3.2.7.1 Germany Genome Editing Market by Technology
13.3.2.7.2 Germany Genome Editing Market by Delivery Method
13.3.2.7.3 Germany Genome Editing Market by Mode
13.3.2.7.4 Germany Genome Editing Market by Application
13.3.2.7.5 Germany Genome Editing Market by End user
13.3.2.8 France
13.3.2.8.1 France Genome Editing Market by Technology
13.3.2.8.2 France Genome Editing Market by Delivery Method
13.3.2.8.3 France Genome Editing Market by Mode
13.3.2.8.4 France Genome Editing Market by Application
13.3.2.8.5 France Genome Editing Market by End user
13.3.2.9 UK
13.3.2.9.1 UK Genome Editing Market by Technology
13.3.2.9.2 UK Genome Editing Market by Delivery Method
13.3.2.9.3 UK Genome Editing Market by Mode
13.3.2.9.4 UK Genome Editing Market by Application
13.3.2.9.5 UK Genome Editing Market by End user
13.3.2.10 Italy
13.3.2.10.1 Italy Genome Editing Market by Technology
13.3.2.10.2 Italy Genome Editing Market by Delivery Method
13.3.2.10.3 Italy Genome Editing Market by Mode
13.3.2.10.4 Italy Genome Editing Market by Application
13.3.2.10.5 Italy Genome Editing Market by End user
13.3.2.11 Spain
13.3.2.11.1 Spain Genome Editing Market by Technology
13.3.2.11.2 Spain Genome Editing Market by Delivery Method
13.3.2.11.3 Spain Genome Editing Market by Mode
13.3.2.11.4 Spain Genome Editing Market by Application
13.3.2.11.5 Spain Genome Editing Market by End user
13.3.2.12 The Netherlands
13.3.2.12.1 Netherlands Genome Editing Market by Technology
13.3.2.12.2 Netherlands Genome Editing Market by Delivery Method
13.3.2.12.3 Netherlands Genome Editing Market by Mode
13.3.2.12.4 Netherlands Genome Editing Market by Application
13.3.2.12.5 Netherlands Genome Editing Market by End user
13.3.2.13 Switzerland
13.3.2.13.1 Switzerland Genome Editing Market by Technology
13.3.2.13.2 Switzerland Genome Editing Market by Delivery Method
13.3.2.13.3 Switzerland Genome Editing Market by Mode
13.3.2.13.4 Switzerland Genome Editing Market by Application
13.3.2.13.5 Switzerland Genome Editing Market by End user
13.3.2.14 Austria
13.3.2.14.1 Austria Genome Editing Market by Technology
13.3.2.14.2 Austria Genome Editing Market by Delivery Method
13.3.2.14.3 Austria Genome Editing Market by Mode
13.3.2.14.4 Austria Genome Editing Market by Application
13.3.2.14.5 Austria Genome Editing Market by End user
13.3.2.15 Rest of Western Europe
13.3.2.15.1 Rest of Western Europe Genome Editing Market by Technology
13.3.2.15.2 Rest of Western Europe Genome Editing Market by Delivery Method
13.3.2.15.3 Rest of Western Europe Genome Editing Market by Mode
13.3.2.15.4 Rest of Western Europe Genome Editing Market by Application
13.3.2.15.5 Rest of Western Europe Genome Editing Market by End user
13.4 Asia-Pacific
13.4.1 Asia Pacific Genome Editing Market by Country
13.4.2 Asia Pacific Genome Editing Market by Technology
13.4.3 Asia Pacific Genome Editing Market by Delivery Method
13.4.4 Asia Pacific Genome Editing Market by Mode
13.4.5 Asia Pacific Genome Editing Market by Application
13.4.6 Asia Pacific Genome Editing Market by End user
13.4.7 China
13.4.7.1 China Genome Editing Market by Technology
13.4.7.2 China Genome Editing Market by Delivery Method
13.4.7.3 China Genome Editing Market by Mode
13.4.7.4 China Genome Editing Market by Application
13.4.7.5 China Genome Editing Market by End user
13.4.8 India
13.4.8.1 India Genome Editing Market by Technology
13.4.8.2 India Genome Editing Market by Delivery Method
13.4.8.3 India Genome Editing Market by Mode
13.4.8.4 India Genome Editing Market by Application
13.4.8.5 India Genome Editing Market by End user
13.4.9 Japan
13.4.9.1 Japan Genome Editing Market by Technology
13.4.9.2 Japan Genome Editing Market by Delivery Method
13.4.9.3 Japan Genome Editing Market by Mode
13.4.9.4 Japan Genome Editing Market by Application
13.4.9.5 Japan Genome Editing Market by End user
13.4.10 South Korea
13.4.10.1 South Korea Genome Editing Market by Technology
13.4.10.2 South Korea Genome Editing Market by Delivery Method
13.4.10.3 South Korea Genome Editing Market by Mode
13.4.10.4 South Korea Genome Editing Market by Application
13.4.10.5 South Korea Genome Editing Market by End user
13.4.11 Vietnam
13.4.11.1 Vietnam Genome Editing Market by Technology
13.4.11.2 Vietnam Genome Editing Market by Delivery Method
13.4.11.3 Vietnam Genome Editing Market by Mode
13.4.11.4 Vietnam Genome Editing Market by Application
13.4.11.5 Vietnam Genome Editing Market by End user
13.4.12 Singapore
13.4.12.1 Singapore Genome Editing Market by Technology
13.4.12.2 Singapore Genome Editing Market by Delivery Method
13.4.12.3 Singapore Genome Editing Market by Mode
13.4.12.4 Singapore Genome Editing Market by Application
13.4.12.5 Singapore Genome Editing Market by End user
13.4.13 Australia
13.4.13.1 Australia Genome Editing Market by Technology
13.4.13.2 Australia Genome Editing Market by Delivery Method
13.4.13.3 Australia Genome Editing Market by Mode
13.4.13.4 Australia Genome Editing Market by Application
13.4.13.5 Australia Genome Editing Market by End user
13.4.14 Rest of Asia-Pacific
13.4.14.1 APAC Genome Editing Market by Technology
13.4.14.2 APAC Genome Editing Market by Delivery Method
13.4.14.3 APAC Genome Editing Market by Mode
13.4.14.4 APAC Genome Editing Market by Application
13.4.14.5 APAC Genome Editing Market by End user
13.5 The Middle East & Africa
13.5.1 Middle East
13.5.1.1 Middle East Genome Editing Market By country
13.5.1.2 Middle East Genome Editing Market by Technology
13.5.1.3 Middle East Genome Editing Market by Delivery Method
13.5.1.4 Middle East Genome Editing Market by Mode
13.5.1.5 Middle East Genome Editing Market by Application
13.5.1.6 Middle East Genome Editing Market by End user
13.5.1.7 UAE
13.5.1.7.1 UAE Genome Editing Market by Technology
13.5.1.7.2 UAE Genome Editing Market by Delivery Method
13.5.1.7.3 UAE Genome Editing Market by Mode
13.5.1.7.4 UAE Genome Editing Market by Application
13.5.1.7.5 UAE Genome Editing Market by End user
13.5.1.8 Egypt
13.5.1.8.1 Egypt Genome Editing Market by Technology
13.5.1.8.2 Egypt Genome Editing Market by Delivery Method
13.5.1.8.3 Egypt Genome Editing Market by Mode
13.5.1.8.4 Egypt Genome Editing Market by Application
13.5.1.8.5 Egypt Genome Editing Market by End user
13.5.1.9 Saudi Arabia
13.5.1.9.1 Saudi Arabia Genome Editing Market by Technology
13.5.1.9.2 Saudi Arabia Genome Editing Market by Delivery Method
13.5.1.9.3 Saudi Arabia Genome Editing Market by Mode
13.5.1.9.4 Saudi Arabia Genome Editing Market by Application
13.5.1.9.5 Saudi Arabia Genome Editing Market by End user
13.5.1.10 Qatar
13.5.1.10.1 Qatar Genome Editing Market by Technology
13.5.1.10.2 Qatar Genome Editing Market by Delivery Method
13.5.1.10.3 Qatar Genome Editing Market by Mode
13.5.1.10.4 Qatar Genome Editing Market by Application
13.5.1.10.5 Qatar Genome Editing Market by End user
13.5.1.11 Rest of Middle East
13.5.1.11.1 Rest of Middle East Genome Editing Market by Technology
13.5.1.11.2 Rest of Middle East Genome Editing Market by Delivery Method
13.5.1.11.3 Rest of Middle East Genome Editing Market by Mode
13.5.1.11.4 Rest of Middle East Genome Editing Market by Application
13.5.1.11.5 Rest of Middle East Genome Editing Market by End user
13.5.2 Africa
13.5.2.1 Africa Genome Editing Market by Country
13.5.2.2 Africa Genome Editing Market by Technology
13.5.2.3 Africa Genome Editing Market by Delivery Method
13.5.2.4 Africa Genome Editing Market by Mode
13.5.2.5 Africa Genome Editing Market by Application
13.5.2.6 Africa Genome Editing Market by End user
13.5.2.7 Nigeria
13.5.2.7.1 Nigeria Genome Editing Market by Technology
13.5.2.7.2 Nigeria Genome Editing Market by Delivery Method
13.5.2.7.3 Nigeria Genome Editing Market by Mode
13.5.2.7.4 Nigeria Genome Editing Market by Application
13.5.2.7.5 Nigeria Genome Editing Market by End user
13.5.2.8 South Africa
13.5.2.8.1 South Africa Genome Editing Market by Technology
13.5.2.8.2 South Africa Genome Editing Market by Delivery Method
13.5.2.8.3 South Africa Genome Editing Market by Mode
13.5.2.8.4 South Africa Genome Editing Market by Application
13.5.2.8.5 South Africa Genome Editing Market by End user
13.5.2.9 Rest of Africa
13.5.2.9.1 Rest of Africa Genome Editing Market by Technology
13.5.2.9.2 Rest of Africa Genome Editing Market by Delivery Method
13.5.2.9.3 Rest of Africa Genome Editing Market by Mode
13.5.2.9.4 Rest of Africa Genome Editing Market by Application
13.5.2.9.5 Rest of Africa Genome Editing Market by End user
13.6 Latin America
13.6.1 Latin America Genome Editing Market by Country
13.6.2 Latin America Genome Editing Market by Technology
13.6.3 Latin America Genome Editing Market by Delivery Method
13.6.4 Latin America Genome Editing Market by Mode
13.6.5 Latin America Genome Editing Market by Application
13.6.6 Latin America Genome Editing Market by End user
13.6.7 Brazil
13.6.7.1 Brazil Genome Editing Market by Technology
13.6.7.2 Brazil Africa Genome Editing Market by Delivery Method
13.6.7.3 Brazil Genome Editing Market by Mode
13.6.7.4 Brazil Genome Editing Market by Application
13.6.7.5 Brazil Genome Editing Market by End user
13.6.8 Argentina
13.6.8.1 Argentina Genome Editing Market by Technology
13.6.8.2 Argentina Genome Editing Market by Delivery Method
13.6.8.3 Argentina Genome Editing Market by Mode
13.6.8.4 Argentina Genome Editing Market by Application
13.6.8.5 Argentina Genome Editing Market by End user
13.6.9 Colombia
13.6.9.1 Colombia Genome Editing Market by Technology
13.6.9.2 Colombia Genome Editing Market by Delivery Method
13.6.9.3 Colombia Genome Editing Market by Mode
13.6.9.4 Colombia Genome Editing Market by Application
13.6.9.5 Colombia Genome Editing Market by End user
13.6.10 Rest of Latin America
13.6.10.1 Rest of Latin America Genome Editing Market by Technology
13.6.10.2 Rest of Latin America Genome Editing Market by Delivery Method
13.6.10.3 Rest of Latin America Genome Editing Market by Mode
13.6.10.4 Rest of Latin America Genome Editing Market by Application
13.6.10.5 Rest of Latin America Genome Editing Market by End user

14 Company Profile
14.1 Merck KGaA
14.1.1Company Overview
14.1.2 Financials
14.1.3 Product/Services Offered
14.1.4 SWOT Analysis
14.1.5 Publishers View
14.2 Cibus
14.2.1Company Overview
14.2.2 Financials
14.2.3 Product/Services Offered
14.2.4 SWOT Analysis
14.2.5 Publishers View
14.3 Recombinetics, Inc.
14.3.1Company Overview
14.3.2 Financials
14.3.3 Product/Services Offered
14.3.4 SWOT Analysis
14.3.5 Publishers View
14.4 Sangamo
14.4.1Company Overview
14.4.2 Financials
14.4.3 Product/Services Offered
14.4.4 SWOT Analysis
14.4.5 Publishers View
14.5 Precision Biosciences
14.5.1Company Overview
14.5.2 Financials
14.5.3 Product/Services Offered
14.5.4 SWOT Analysis
14.5.5 Publishers View
14.6 CRISPR Therapeutics
14.6.1Company Overview
14.6.2 Financials
14.6.3 Product/Services Offered
14.6.4 SWOT Analysis
14.6.5 Publishers View
14.7 Intellia Therapeutics, Inc.
14.7.1Company Overview
14.7.2 Financials
14.7.3 Product/Services Offered
14.7.4 SWOT Analysis
14.7.5 Publishers View
14.8 Caribou Biosciences Inc.
14.8.1Company Overview
14.8.2 Financials
14.8.3 Product/Services Offered
14.8.4 SWOT Analysis
14.8.5 Publishers View
14.9 AstraZeneca
14.9.1Company Overview
14.9.2 Financials
14.9.3 Product/Services Offered
14.9.4 SWOT Analysis
14.9.5 Publishers View
14.10 Takara Bio USA
14.10.1Company Overview
14.10.2 Financials
14.10.3 Product/Services Offered
14.10.4 SWOT Analysis
14.10.5 Publishers View
14.11 Horizon Discovery Group plc
14.11.1Company Overview
14.11.2 Financials
14.11.3 Product/Services Offered
14.11.4 SWOT Analysis
14.11.5 Publishers View
14.12 Integrated DNA Technologies Inc.
14.12.1Company Overview
14.12.2 Financials
14.12.3 Product/Services Offered
14.12.4 SWOT Analysis
14.12.5 Publishers View
14.13 Egenesis Inc.
14.13.1Company Overview
14.13.2 Financials
14.13.3 Product/Services Offered
14.13.4 SWOT Analysis
14.13.5 Publishers View
14.14 GenScript
14.14.1Company Overview
14.14.2 Financials
14.14.3 Product/Services Offered
14.14.4 SWOT Analysis
14.14.5 Publishers View
14.15 New England Biolabs
14.15.1Company Overview
14.15.2 Financials
14.15.3 Product/Services Offered
14.15.4 SWOT Analysis
14.15.5 Publishers View
14.16 OriGene Technologies, Inc.
14.16.1Company Overview
14.16.2 Financials
14.16.3 Product/Services Offered
14.16.4 SWOT Analysis
14.16.5 Publishers View
14.17 Lonza
14.17.1Company Overview
14.17.2 Financials
14.17.3 Product/Services Offered
14.17.4 SWOT Analysis
14.17.5 Publishers View
14.18 Thermo Fisher Scientific, Inc.
14.18.1Company Overview
14.18.2 Financials
14.18.3 Product/Services Offered
14.18.4 SWOT Analysis
14.18.5 Publishers View

15. Competitive Landscape
15.1 Competitive Bench marking
15.2 Market Share Analysis
15.3 Recent Developments
15.3.1 Industry News
15.3.2 Company News
15.3.3 Mergers & Acquisitions

16. USE Cases and Best Practices

17. Conclusion

Users

Single User, Enterprise User

Select your currency
USD United States (US) dollar